Medicamen Organics Limited — Others, 15-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Medicamen Organics Limited has announced a board meeting to review the Reconciliation of Share Capital Audit Report for the quarter ended December 31, 2024, as submitted to the National Stock Exchange of India. The report confirms that the total issued capital remains at 1.17 crore shares, with no discrepancies noted in the share capital since the previous quarter. This compliance underlines the company's commitment to transparency and governance. For investors, this positive disclosure may enhance confidence in the company's operational consistency and adherence to financial regulations.